Phentermine and tirzepatide: can you take them together?

If you're managing your weight with tirzepatide or exploring your options, you may have come across phentermine as a possible add-on. This article covers how phentermine and tirzepatide work, how they differ, and what the current evidence actually says about using them together.

You usually can’t take phentermine and tirzepatide together, especially without close supervision from a healthcare provider. In fact, the label for phentermine cautions against combining it with other medications for weight loss, since safety hasn’t been evaluated. Any combined use would be entirely off-label.

That said, there’s interest in combining anti-obesity medications. The thinking is that targeting multiple pathways at once may produce better results for people who don't respond adequately to one drug alone.

But the risks of this pairing haven't been formally studied.

Fastest-working GLP-1 for faster weight loss

See if you qualify

No published randomized controlled trials have evaluated phentermine and tirzepatide together. The closest available data involves a different GLP-1 receptor agonist.

In a small study of 45 adults with obesity who had already been on liraglutide (Saxenda) for one year, adding phentermine produced no meaningful additional weight loss compared to placebo.

The study was limited by its small size and the fact that the GLP-1 agonist was started before phentermine, which may have affected the outcome.

There’s also a published case report of a 23-year-old with severe obesity who was taking phentermine, topiramate, metformin, and bupropion. Their body mass index (BMI) remained unchanged on this regimen until semaglutide was added, after which they lost 32.5% of their total body weight.

But remember, semaglutide is different from tirzepatide, and a single case cannot (and does not) establish safety.

Phentermine has been on the market since 1959 as a short-term support for weight management. It’s meant to be used along with a lower-calorie diet and regular exercise.

It’s typically recommended for people with a BMI over 30, or for those with a BMI over 27 who also have a weight-related health condition, like high blood pressure or diabetes.

Phentermine works by stimulating the release of norepinephrine, a chemical messenger in the brain that can suppress appetite. It's a Schedule IV controlled substance, meaning it carries a recognized risk for misuse or dependence. 

Phentermine is approved for short-term use only, typically a few weeks. When combined with topiramate (as Qsymia), clinical trial data shows roughly 70% of people lost about 5%–10% of their body weight over 56 weeks.

So, if you started at 160 pounds, for example, that would mean losing about 8–16 pounds.

Tirzepatide is a once-weekly injection that’s used alongside lifestyle changes. It targets two hormone receptors, GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). It’s available under two brand names.

• Mounjaro was approved in 2022 to improve blood sugar control in people with type 2 diabetes.

• Zepbound was approved in 2023 for chronic weight management in adults with obesity or with overweight and at least one weight-related condition. It’s also approved to treat moderate to severe obstructive sleep apnea in adults with obesity. 

Tirzepatide is also sometimes prescribed off-label for weight loss in people who don't meet the formal criteria for these approved uses.

Unlike phentermine, tirzepatide is designed for long-term, ongoing use rather than a few weeks. In the SURMOUNT-1 clinical trial, people taking tirzepatide lost between 15% and 20.9% of their body weight over 72 weeks, depending on dose, compared to just 3.1% in the placebo group.

These results make it a very different tool from older weight loss medications like phentermine.

For people wondering, “can I take phentermine and Mounjaro together?” or “can I take phentermine and Zepbound together?”, the answer is usually no. Phentermine and tirzepatide work through very different mechanisms and produce very different results.

Understanding these differences can help clarify why combining them isn't as straightforward as it might seem.

*With manufacturer offer

The biggest safety concern with combining phentermine and tirzepatide comes down to heart health. Phentermine is a stimulant. It can cause irregular or rapid heartbeat, increased blood pressure, and, in severe cases, circulation collapse.

Because of this, it cannot be used by people with a history of heart disease, stroke, irregular heartbeat, heart failure, or uncontrolled high blood pressure. It's also not prescribed for people with an overactive thyroid, glaucoma, or a history of drug abuse.

This matters because many of these conditions are more common in people with obesity, making careful screening especially important before considering phentermine.

Tirzepatide can also have some effects on the heart. Across the SURPASS clinical trials, it raised heart rate by an average of 1–4 beats per minute at 5 mg, and up to 3–6 beats per minute at 15 mg.

On the positive side, tirzepatide also lowered systolic blood pressure by approximately 2.8 to 12.6 mmHg across doses, largely because of the weight loss it produces.

What happens when you combine both medications is simply not known. No studies have looked at how phentermine's stimulant effects interact with tirzepatide's cardiovascular profile, and that evidence gap is a reason for caution.

Tirzepatide itself has a strong evidence base, with clinical trials showing up to 20.9% body weight reduction over 72 weeks when used alongside diet and exercise. For many people, it produces significant results on its own, without needing other medications.

But if tirzepatide alone isn't producing adequate weight loss for you, it’s still worth having a conversation with your provider to see if they would recommend an additional medication for you.

Any decisions about combination anti-obesity treatment should be made in partnership with a healthcare provider who can evaluate your full medical history, cardiovascular risk factors, and individual treatment goals.

Ro providers are available to help you explore your options.

Get started

There isn't enough evidence to recommend taking phentermine and tirzepatide together, and there are real safety concerns worth taking seriously.

Here's what to keep in mind:

• There is no clinical evidence to support combining the two medications. No randomized controlled trials have studied phentermine and tirzepatide together, and no guidelines recommend the combination. Any use would be off-label.

• Phentermine, in particular, can pose a cardiovascular risk. Phentermine raises heart rate and can increase blood pressure. It’s not to be prescribed to people who have certain cardiovascular conditions common in those with obesity.

• Tirzepatide can be highly effective for weight loss on its own. Clinical trials show up to 20.9% body weight reduction over 72 weeks, depending on dose. It's worth reaching the highest tolerated dose before considering anything else.

Any decision to combine weight loss medications needs medical oversight. A provider who knows your full history, risk factors, and goals can help determine what makes sense for you.